The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Abstract
The vertebrate immune system recognizes bacterial DNA based on the presence of unmethylated CpG-dinucleotides in particular base contexts (“CpG motifs”). In contrast to mice, knowledge about CpG-mediated effects on human B cells is poor. In the present study we identify and determine an optimal human CpG motif. A phosphodiester oligonucleotide containing this motif strongly stimulated CD86, CD40, CD54, and MHC class II expression, IL-6 synthesis, and proliferation of primary human B cells. These effects required internalization of the oligonucleotide and endosomal maturation. The molecular mechanism of action of this CpG motif was associated with the sustained induction of the NF-κB p50/p65 heterodimer and of the transcription-factor complex AP-1. Transcription-factor activation by CpG DNA was preceded by increased phosphorylation of the stress kinases c-Jun N-terminal kinase and p38, and of activating transcription factor-2. In contrast to CpG, signaling through the B cell receptor led to activation of extracellular receptor kinase and to phosphorylation of a different isoform of c-Jun N-terminal kinase. These studies define the structure of a highly active human CpG motif and characterize its molecular mechanism of action in primary human B cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although GTCGTT has been proposed as an optimal human TLR9 activating sequence, other sequences of CpG ODN are also activating and questions remain regarding the potency of activation through sequence context, TLR secondary structure, and cell type [96][97][98].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [96]
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationA MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J. D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,647
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P. T., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,601
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,423
Determination of lymphocyte division by flow cytometry
Lyons, A. B., & Parish, C. R. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90236-4 · Cited by 1,650
Transcription Factor ATF2 Regulation by the JNK Signal Transduction Pathway
Gupta, S., Campbell, D., Dérijard, B., & Davis, R. J. (1995) · Science · doi:10.1126/science.7824938 · Cited by 1,433
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. Μ., Lehmann, P., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,001
Self-citationBallas, Z. K., Rasmussen, W. L., & KRIEG, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 758
Self-citationDavis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L. T., Schorr, J., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 676
Self-citationHäcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R. M., Sparwasser, T. D., Heeg, K. M., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 670
CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
Hartmann, G., Weiner, G. J., & KRIEG, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9305 · Cited by 623
Self-citationMacrophages ingest and are activated by bacterial DNA
Stacey, K. J., Sweet, M. J., & Hume, D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2116 · Cited by 573
Kline, J. N., Waldschmidt, T. J., Businga, T. R., Lemish, J. E., Weinstock, J. V., Thorne, P. S., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2555 · Cited by 563
Self-citationModulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.
Kline, J. N., Waldschmidt, T. J., Businga, T. R., Lemish, J. E., Weinstock, J. V., Thorne, P. S., & KRIEG, A. M. (1998) · PubMed · Cited by 546
Self-citationJakob, T., Walker, P., Krieg, A. Μ., Udey, M. C., & Vogel, J. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3042 · Cited by 535
Self-citationWeiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. Μ. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 516
Self-citationATF‐2 contains a phosphorylation‐dependent transcriptional activation domain.
Livingstone, C., Patel, G., & Jones, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07167.x · Cited by 494
Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3627 · Cited by 472
Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K. M. (1998) · PubMed · Cited by 455
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
Angel, P., & Karin, M. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90011-9 · Cited by 450
Cowdery, J. S., Chace, J. H., Yi, A., & KRIEG, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4570 · Cited by 423
Self-citationKrieg, A. Μ., Love-Homan, L., Yi, A., & Harty, J. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2428 · Cited by 377
Self-citationType I Interferon-mediated Stimulation of T Cells by CpG DNA
Sun, S., Zhang, X. M., Tough, D. F., & Sprent, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2335 · Cited by 360
Millan, C. L. B., Weeratna, R. D., Krieg, A. Μ., Siegrist, C., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15553 · Cited by 344
Self-citationYi, A., Tuetken, R. S., Redford, T. W., Waldschmidt, M., Kirsch, J. D., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4755 · Cited by 325
Self-citationCpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
Moldoveanu, Z., Love-Homan, L., Huang, W. Q., & Krieg, A. Μ. (1998) · Vaccine · doi:10.1016/s0264-410x(98)80122-9 · Cited by 307
Self-citationBacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12
Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. Μ., & Cowdery, J. S. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4380 · Cited by 285
Self-citationActivation of human B cells by phosphorothioate oligodeoxynucleotides.
Liang, H., Nishioka, Y., Reich, C. F., Pisetsky, D. S., & Lipsky, P. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118894 · Cited by 284
Yi, A., Klinman, D. M., Martin, T. L., Matson, S., & KRIEG, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5394 · Cited by 281
Self-citationSequential Induction of NF-κB/Rel Family Proteins during B-Cell Terminal Differentiation
Liou, H., Sha, W. C., Scott, M. L., & Baltimore, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5349-5359.1994 · Cited by 267
Macfarlane, D. E., & Manzel, L. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1122 · Cited by 257
The role of CpG dinucleotides in DNA vaccines
Krieg, A. Μ., Yi, A., Schorr, J., & Davis, H. L. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01145-1 · Cited by 247
Self-citationYi, A., Chang, M., Peckham, D. W., Krieg, A. Μ., & Ashman, R. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5898 · Cited by 239
Self-citationPervasive CpG suppression in animal mitochondrial genomes
Cardon, L. R., Burge, C., Clayton, D. A., & Karlin, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3799 · Cited by 238
Cutting Edge: Rapid Induction of Mitogen-Activated Protein Kinases by Immune Stimulatory CpG DNA
Yi, A., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4493 · Cited by 214
Self-citationRapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.
Yi, A., & KRIEG, A. M. (1998) · PubMed · Cited by 208
Self-citationCpG DNA and LPS induce distinct patterns of activation in human monocytes
Hartmann, G., & KRIEG, A. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300880 · Cited by 205
Self-citationWooldridge, J. E., Ballas, Z. K., Krieg, A. Μ., & Weiner, G. J. (1997) · Blood · doi:10.1182/blood.v89.8.2994 · Cited by 202
Self-citationSequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.
Liou, H., Sha, W. C., Scott, M. L., & Baltimore, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5349 · Cited by 137
Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1
Branda, R. F., Moore, A. L., Mathews, L., McCormack, J. J., & Zon, G. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90014-n · Cited by 119
Hartmann, G., Krug, A., Waller-Fontaine, K., & Endres, S. (1996) · Molecular Medicine · doi:10.1007/bf03401902 · Cited by 88
Self-citationYamamoto, T., Yamamoto, S., Kataoka, T., Komuro, K., Kohase, M., & Tokunaga, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02947.x · Cited by 85
Hartmann, G., Krug, A., Bidlingmaier, M., Hacker, U. T., Eigler, A., Albrecht, R., Strasburger, C. J., & Endres, S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37460-9 · Cited by 59
Self-citationCrompton, T., Outram, S. V., Buckland, J., & Owen, M. J. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199806)28:06 · Cited by 49
Amplification of antibody production by phosphorothioate oligodeoxynucleotides
Branda, R. F., Moore, A. L., Lafayette, A., Mathews, L., Hong, R., Zon, G., Brown, T., & McCormack, J. J. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90035-9 · Cited by 47
Specific Suppression of Human Tumor Necrosis Factor-α Synthesis by Antisense Oligodeoxynucleotides
Hartmann, G., Krug, A., Eigler, A., Moeller, J., MURPHY, J., Albrecht, R., & Endres, S. (1996) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1996.6.291 · Cited by 36
Self-citationNonspecific Suppression of [ 3 H]Thymidine Incorporation by "Control" Oligonucleotides
Matson, S., & Krieg, A. Μ. (1992) · Antisense Research and Development · doi:10.1089/ard.1992.2.325 · Cited by 31
Self-citationBranda, R. F., Moore, A. L., Hong, R., McCormack, J. J., Zon, G., & Cunningham‐Rundles, C. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0058 · Cited by 30
Research works printed but not linked: 44
- 1994, Proc. Natl. Acad. Sci. USA, 3799
- 1995, Nature, 546
- 1998, J. Immunol., 5898
- 1998, Trends Microbiol., 23
- 1998, J. Exp. Med., 2335
- 1996, J. Immunol., 2116
- 1997, Clin. Immunol. Immunopathol., 185
- 1998, EMBO J., 6230
- 1998, Eur. J. Immunol., 2045
- 1998, J. Immunol., 3042
- 1996, J. Immunol., 4570
- 1996, J. Immunol., 1840
- 1998, J. Immunol., 4493
- 1996, J. Immunol., 5394
- 1998, J. Immunol., 4755
- 1997, Proc. Natl. Acad. Sci. USA, 10833
- 1998, Vaccine, 1216
- 1998, J. Immunol., 870
- 1998, Proc. Natl. Acad. Sci. USA, 15553
- 1998, J. Immunol., 3627
- 1997, J. Exp. Med., 1623
- 1997, Blood, 2994
- 1998, J. Immunol., 2428
- 1998, J. Immunol., 2555
- 1994, Jpn. J. Cancer Res. (GANN), 775
- 1996, Clin. Immunol. Immunopathol., 115
- 1993, Biochem. Pharmacol., 2037
- 1996, J. Lab. Clin. Med., 329
- 1996, J. Clin. Invest., 1119
- 1996, Mol. Med., 429
- 1999, Gene Ther., 893
- 1999, Proc. Natl. Acad. Sci. USA, 9305
- 1996, Antisense Nucleic Acid Drug Dev., 291
- 1998, J. Pharmacol. Exp. Ther., 920
- 1994, J. Immunol. Methods, 131
- 1998, J. Immunol., 1122
- 1995, J. Biol. Chem., 16483
- 1991, Biochim. Biophys. Acta, 129
- 1995, Science, 389
- 1992, Antisense Res. Dev., 325
- 1994, Mol. Cell. Biol., 5349
- 1994, Nature, 156
- 1994, Science, 808
- 1995, EMBO J., 1785
Cited by
Sorted by citations
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. Μ. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,598
Self-citationKadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Hornung, V., Rothenfußer, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,970
Self-citationTherapeutic potential of Toll-like receptor 9 activation
Krieg, A. Μ. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,244
Self-citationHornung, V., Guenthner‐Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A. M., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,261
Self-citation
Metadata
- Authors
- Hartmann, G., & Krieg, A. M.
- Affiliations
- University of Iowa (US)
- Department of Internal Medicine, University of Iowa , Iowa City, IA 52242
- ORCID
- Hartmann, Gunther
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01
- Volume
- 164
- Issue
- 2
- Pages
- 944-953
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1956007715
- Cited by
- 605
- References
- 48
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 11 · 2021: 14 · 2020: 11 · 2019: 7 · 2018: 12 · 2017: 21 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 22 · 2012: 24
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01-CA66570, P01CA066570)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-25295, P30DK025295)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- B cell activation, endosomal maturation, AP-1, c-Jun N-terminal kinase, p38 MAPK, ATF2, B cell receptor signaling, interleukin-6, MHC class II expression, CD40, CD86, ICAM-1
- MeSH terms
- B-Lymphocytes, Base Sequence, Binding Sites, DNA, HLA-D Antigens, Humans, Hydrogen-Ion Concentration, Lymphocyte Activation, Oligodeoxyribonucleotides, Phosphorylation, Endosomes, Thionucleotides, Transcription Factors, Interleukin-6, NF-kappa B, Cyclic AMP Response Element-Binding Protein, Intercellular Adhesion Molecule-1, Transcription Factor AP-1, CpG Islands, CD40 Antigens, Mitogen-Activated Protein Kinases, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Activating Transcription Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review